Squarepoint Ops LLC Myovant Sciences Ltd. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$24.03 - $27.02 $1.5 Million - $1.69 Million	-62,486 Reduced 74.12%	21,820 $588,000
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $977,949 - $1.72 Million	84,306 New	84,306 $1.51 Million
Q1 2021 May 17, 2021	SELL	$20.46 - $25.18 $584,071 - $718,813	-28,547 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$13.8 - $27.62 $210,463 - $421,232	15,251 Added 114.7%	28,547 $788,000
Q3 2020 Nov 16, 2020	SELL	$14.05 - $22.6 $107,580 - $173,048	-7,657 Reduced 36.54%	13,296 $187,000
Q2 2020 Aug 14, 2020	BUY	$7.34 - $20.84 $153,795 - $436,660	20,953 New	20,953 $432,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.